NCT05531032

Brief Summary

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

August 30, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 7, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

April 13, 2025

Status Verified

November 1, 2024

Enrollment Period

2.2 years

First QC Date

August 30, 2022

Last Update Submit

April 9, 2025

Conditions

ARDSCOVID-19 PneumoniaExtracorporeal Membrane Oxygenation

Outcome Measures

Primary Outcomes (1)

  • HRQOL after COVID-19 ARDS and ECMO therapy

    Health-related quality of life will be delineated by means of a quantitative questionnaire.

    1 year

Interventions

Phone InterviewOTHER

Phone interview questionnaire

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients surviving COVID-19 ARDS and ECMO therapy

You may not qualify if:

  • no consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, Austria

Location

Study Officials

  • Alexander Hermann, Dr.

    MUW

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Phone Interview
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 30, 2022

First Posted

September 7, 2022

Study Start

August 30, 2022

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

April 13, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations

AU(1)